Navigation Links
CEL-SCI Study Shows CEL-2000 Vaccine Blocks Progression of Rheumatoid Arthritis
Date:2/22/2010

ment."

In these studies, mice were injected with collagen to induce the autoimmune (RA) disease.  Therapy with Enbrel or CEL-2000 was initiated after disease (RA) symptoms have been established and treatment continued for 28 days after the initiation of a significant, uniform, and measurable level of arthritic disease in groups of mice.  CEL-2000 was administered only twice, however Enbrel had to be administered every other day for the 28 day study period (as indicated for Enbrel use). The extent of disease, as measured by deformation of foot joints (Arthritic Index (AI) score), of untreated animals and any improvements resulting from CEL-2000 and Enbrel treated animal were then compared.  In another study, CEL-2000 was administered 5 times over a 70 day period and the animals were monitored for a total study period of 90 days.   In each case, CEL-2000 treatment proved effective in blocking progression of disease (RA) with statistically significant reduction in AI score compared to controls.  The CEL-2000 treatment was deemed safe and well tolerated without any reported adverse effects related to treatment.  

The CEL-2000 treatment appeared to change the course of the immune response in the diseased (RA) animals, limiting the development of the destructive action of Th17 and tumor necrosis factor alpha (TNF-alpha).  Analysis of serum levels of 21 cytokines/chemokines after 10 days of CEL-2000 treatment indicated reductions in the characteristic cytokine markers of rheumatoid arthritis, TNF-alpha and IL-17, as well a
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. CEL-SCI Corporation Releases Letter to Shareholders
2. CEL-SCI Corporation Reports First Quarter 2010 Financial Results
3. CEL-SCI to Present at 12th Annual BIO CEO & Investor Conference
4. CEL-SCI Hires Vice President of Manufacturing/Facilities and Commercial Operations
5. CEL-SCI Completes Validation of Manufacturing Facility Allowing It To Commence Manufacturing of Multikine
6. CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine
7. CEL-SCI Corporation Releases Letter to Shareholders
8. CEL-SCI Hires Clinical Research Organization for Clinical Study With Hospitalized H1N1-Infected Patients
9. CEL-SCI Expands H1N1 Flu Virus Work
10. CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series
11. CEL-SCI Posts New Corporate Presentation to Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 21, 2013   ... where world,s health ministers gather to address the large ... Mental and neurological disorders (MNDs) affect 700 million people ... disease (NCD) burden ,Do You Mind?, helps ... role each can play to collectively address MNDs , ...
(Date:5/20/2013)... -- Volcano Corporation (NASDAQ: VOLC ) a leading ... to enhance the diagnosis and treatment of coronary and ... efforts to expand research and innovation surrounding its physiology ... ® (Instant Wave-Free Ratio™) 1 technologies, via ... 2013 in Paris . ...
(Date:5/20/2013)... , May 20, 2013  B. Braun Medical ... and environmental safety with products, services and education ... feature its innovative Outlook® 400ES and Space Infusion ... capabilities at the American Association of Critical-Care Nurses ... Boston Convention Center. ...
Breaking Medicine Technology:Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign to Fight Mental and Neurological Disorders 2Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 2Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 3Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 4B. Braun Committed To Improving Patient Safety 2
(Date:5/21/2013)... 2013 The National Resident Matching ... transitions for its Board of Directors. Hal B. ... University School of Medicine, has been named President. ... the University of California San Diego, is the President-Designate, ... the Nebraska Medical Center, is the Secretary-Treasurer. Kenneth ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 It took ... in prison for his sixth time on a fifteen ... Prison warden Frank Eyman to trust him enough to ... with other addicted inmates. “NarcoNon” Willie intended to name ... did finally get permission and did start up that ...
(Date:5/21/2013)... Leading New Jersey real estate agent, ... One of her favorite aspects of walkable places is ... light of the current childhood obesity epidemic that plagues ... walkable living. , A New York Academy of Sciences ... neighborhoods as a key combatant to obesity. The same ...
(Date:5/21/2013)... Dr. James C. Wittig, Chief of Orthopedic Oncology ... of the John Theurer Cancer Center at Hackensack University ... of the top 13 Orthopedic Oncologists in the United ... one of approximately 125 surgeons in America who specialize ... thought leaders in the field of Oncology. Dr. Wittig’s ...
(Date:5/21/2013)... 21, 2013 The Michigan Lupus Foundation ... Lapeer on , June 11th. , Meeting Details: , ... Regional Medical Center,     Conference Room 5 (Lower Level),     1375 ... are designed to assist people with lupus and their ... and to get a better understanding of this disease ...
Breaking Medicine News(10 mins):Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 2Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 3Health News:Narconon Releases Report on its Very First Narconon Program, the First of 23 Reviews or Evaluations of Results up to 2009 2Health News:Narconon Releases Report on its Very First Narconon Program, the First of 23 Reviews or Evaluations of Results up to 2009 3Health News:Narconon Releases Report on its Very First Narconon Program, the First of 23 Reviews or Evaluations of Results up to 2009 4Health News:Narconon Releases Report on its Very First Narconon Program, the First of 23 Reviews or Evaluations of Results up to 2009 5Health News:New Jersey Realtor, Lina Panza, Advocates Walkable Neighborhoods to Combat Childhood Obesity 2Health News:New Jersey Realtor, Lina Panza, Advocates Walkable Neighborhoods to Combat Childhood Obesity 3Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 2Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 3
... carcinoma (HCC) patients in China may be treated with ... doubt its effectiveness. These stated that a research group ... of PTEN in HCC, which may suppress tumor cell ... A research article published on January 7, 2008 ...
... A procedure called carotid artery stenting (CAS) has ... carotid endarterectomy (CEA), for patients with dangerous narrowing of ... questions remain about the best uses of this procedureespecially ... "low-risk" patients, according to a special article in the ...
... 2008A research team from Universit Lavals Faculty of Medicine ... by the use of antipsychotic drugswhich in extreme cases ... one monthcan be avoided through a specially designed weight ... and kinesiologist Angelo Tremblay report the details of their ...
... team of Tchernev and Petrova from Alexandrovska Hospital in ... by chronic Hepatitis C virus (HCV). They were intrigued ... on the lower limbs, acute pain in the joints, ... They were also intrigued by the presence of cryoglobulins ...
... digestive enzyme specifically produced in the gastric mucosa. Human ... immunological properties, PGI and PGII. Serum PG levels seem ... in the stomach, and used as "serological biopsy." In ... on the identification of individuals for intervention studies, whereas ...
... for treatment of patients with chronic hepatitis B ... leads to the emergence of lamivudine-resistant hepatitis B ... with HBV. Sensitive methods for early detection of ... in treating patients with HBV infection. , To ...
Cached Medicine News:Health News:How does Fu-Zheng-Jie-Du-Decoction act on PTEN expression in hepatocellular carcinoma? 2Health News:Vascular surgeons ask, what's next for carotid artery stenting? 2Health News:Weight gain induced by antipsychotic drugs can be avoided 2Health News:Attention: Extra-hepatic manifestation of hepatitis C virus infection 2Health News:What are the essential characteristics of serum PG in Chinese? 2Health News:What is the more suitable for early detection of low abundant lamivudine-resistant mutants? 2
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... "pipette/tip" system ensures utmost accuracy and precision. ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Medicine Products: